|
Website:
http://www.boehringer-ingelheim.com
Phone: +49 61 32 77 0 |
Address:
Binger Strasse 173
55216 Ingelheim, |
Company Description
Boehringer Ingelheim. The Group's principal activity is to manufacture, research and market of pharmaceutical products. The Group operates in two segments: Human Pharmaceuticals and Animal Health. Human Pharmaceuticals segment is sub divided into Prescription medicines, Consumer Health Care and Industrial Customer activities, which comprises chemicals, biopharmaceuticals and pharmaceutical manufacture. Animal Health segment introduces new products and product concepts for the treatment and prevention of diseases for animals. The Group also offers treatments for cancer and AIDS.
Key People
| Chairman | Dr. Alessandro Banchi |
| Chairman | Prof. Michael Hoffmann-Becking |
Related Business Topics
Breaking News
Reuters - 7 hours ago
COLUMBUS, Ohio, Nov. 10 /PRNewswire/ -- Roxane Laboratories, Inc. announced today the approval of its Abbreviated New Drug Application (ANDA) for Perindopril Erbumine Tablets, 2mg, 4mg and 8mg by the U.S. Food and Drug Administration. The product is ...
Forbes.com - November 04, 2009 8:32 AM
BusinessWire - Legal IQ and IQPC will hold the 8th eDiscovery conference December 7-9, 2009 at the Altman Building in New York, NY (www.ediscoveryevent.com/main). This conference brings together professionals involved in eDiscovery to share practical ...
CNBC - October 30, 2009 11:01 AM
NEW YORK - Shares of Idenix Pharmaceuticals Inc. fell Friday after the company said Novartis AG will not exercise an option to license the company's lead drug candidate, aimed at treating hepatitis C. The stock fell 38 cents, or 15.2 percent, to $2.12 in ...
CNBC - October 30, 2009 10:09 AM
NEW YORK - Shares of biotechnology company Exelixis Inc. rose Friday after the company narrowed its profit loss on a surge in revenue from partnerships with several large pharmaceutical companies. The stock rose 57 cents, or 10 percent, to $6.28 in ...
Reuters - October 28, 2009 8:04 PM
DUBLIN--(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/7f327f/commercial_insight) has announced the addition of the 'Commercial Insight: Parkinson's Disease - Japan and Europe to Drive Total Market Growth' report to ...
Pharmaceutical Companies
Daily Drug Pipeline Updates Pharmaceutical Company Profiles
www.biopharminsight.com
Daily Drug Pipeline Updates Pharmaceutical Company Profiles
www.biopharminsight.com
Free Prescription Drugs
Free Medicine from 270+ Programs For Low Income Americans Under 65
www.scbn.org
Free Medicine from 270+ Programs For Low Income Americans Under 65
www.scbn.org
Free Prescription Program
Get Completely Free Medication from Over 270 Assistance Programs Today
www.FreeMedicineRevolution.com
Get Completely Free Medication from Over 270 Assistance Programs Today
www.FreeMedicineRevolution.com
